
    
      A dose escalation study evaluating the safety and efficacy of human amniotic epithelial
      cells( hAECs) in preventing acute graft-versus-host(aGVHD) disease after hematopoietic stem
      cell transplantation(HSCT). The doses were 1×10^6、2×10^6、5×^6 cell/kg, successively.
    
  